Dihydroartemisinin–piperaquine versus chloroquine for the treatment of uncomplicated Plasmodium vivax malaria with concurrent or delayed high-dose primaquine in Brazil (Curavivax): an open-label, single-centre, randomised clinical trial

Dihydroartemisinin–piperaquine versus chloroquine for the treatment of uncomplicated Plasmodium vivax malaria with concurrent or delayed high-dose primaquine in Brazil (Curavivax): an open-label, single-centre, randomised clinical trial Djane C Baía-da-Silva, PhDa,b ∙ Kim Vinícius AmaralC Machado, PhDb,c ∙ Amanda Lia RebêloC Rabelo, MScb,c ∙ Antônio AlcirleyC da Silva Balieiro, PhDa ∙ Antônio S LC Barbosa, BScd ∙ Mônica Regina FariasC Costa, MScd ∙ et al. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00139-8/abstract?dgcid=raven_jbs_etoc_feature_laninf